Feedback

Lymphoma of the Mediastinum

Marcus P. Watkins, Nancy L. Bartlett
Lymphoma of the Mediastinum is a topic covered in the Pearson's General Thoracic.

To view the entire topic, please or .

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

-- The first section of this topic is shown below --

Key Points

  • Confirm specimen handling with the pathologist prior to the procedure in any patient with suspected intrathoracic lymphoma. Tissue may need to be transported in saline to allow for flow cytometric analysis.
  • Chest tubes are usually unnecessary for management of pleural effusions in patients with newly diagnosed lymphoma. Effusions often resolve rapidly following the initiation of chemotherapy.
  • Nodular sclerosis Hodgkin lymphoma and primary mediastinal large B-cell lymphoma are the most common mediastinal lymphomas and are often difficult to distinguish. Both are associated with extensive fibrosis, and large biopsies are often required to identify diagnostic malignant cells.
  • Lymphoblastic lymphoma of the mediastinum, seen most commonly in children and young adult men, is a medical emergency requiring urgent initiation of therapy.
  • Most patients with Hodgkin lymphoma or large cell lymphoma of the mediastinum have substantial residual masses after successful therapy, and repeat biopsy is not indicated in most cases.

Lymphomas are malignant neoplasms of lymphocytes and their precursor cells, the principal cellular elements of the immune system. Historically, lymphomas were classified merely by their histologic appearance, specifically cell size and architecture. The current classification system is the 2016 World Health Organization (WHO) system, which defines specific subcategories of lymphoma according to the immunologic, molecular, genetic, and clinical characteristics of the lymphoma cells as well as the morphology.[1][2]

Although most subtypes of lymphoma can potentially involve the mediastinum or lungs, only a few present as an isolated mediastinal or pulmonary mass. Those with the potential for a primary thoracic presentation are the focus of this chapter, specifically Hodgkin lymphoma (HL), primary mediastinal large B-cell lymphoma (PMBL), lymphoblastic lymphoma, and pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma. We discuss the pathology, clinical and laboratory features, staging, treatment, complications, and prognosis for each of these subtypes when they present in the mediastinum or lung.

-- To view the remaining sections of this topic, please or --

Key Points

  • Confirm specimen handling with the pathologist prior to the procedure in any patient with suspected intrathoracic lymphoma. Tissue may need to be transported in saline to allow for flow cytometric analysis.
  • Chest tubes are usually unnecessary for management of pleural effusions in patients with newly diagnosed lymphoma. Effusions often resolve rapidly following the initiation of chemotherapy.
  • Nodular sclerosis Hodgkin lymphoma and primary mediastinal large B-cell lymphoma are the most common mediastinal lymphomas and are often difficult to distinguish. Both are associated with extensive fibrosis, and large biopsies are often required to identify diagnostic malignant cells.
  • Lymphoblastic lymphoma of the mediastinum, seen most commonly in children and young adult men, is a medical emergency requiring urgent initiation of therapy.
  • Most patients with Hodgkin lymphoma or large cell lymphoma of the mediastinum have substantial residual masses after successful therapy, and repeat biopsy is not indicated in most cases.

Lymphomas are malignant neoplasms of lymphocytes and their precursor cells, the principal cellular elements of the immune system. Historically, lymphomas were classified merely by their histologic appearance, specifically cell size and architecture. The current classification system is the 2016 World Health Organization (WHO) system, which defines specific subcategories of lymphoma according to the immunologic, molecular, genetic, and clinical characteristics of the lymphoma cells as well as the morphology.[1][2]

Although most subtypes of lymphoma can potentially involve the mediastinum or lungs, only a few present as an isolated mediastinal or pulmonary mass. Those with the potential for a primary thoracic presentation are the focus of this chapter, specifically Hodgkin lymphoma (HL), primary mediastinal large B-cell lymphoma (PMBL), lymphoblastic lymphoma, and pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma. We discuss the pathology, clinical and laboratory features, staging, treatment, complications, and prognosis for each of these subtypes when they present in the mediastinum or lung.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: January 5, 2021